156 related articles for article (PubMed ID: 32558383)
21. Genotype and phenotype spectrum of NRAS germline variants.
Altmüller F; Lissewski C; Bertola D; Flex E; Stark Z; Spranger S; Baynam G; Buscarilli M; Dyack S; Gillis J; Yntema HG; Pantaleoni F; van Loon RL; MacKay S; Mina K; Schanze I; Tan TY; Walsh M; White SM; Niewisch MR; García-Miñaúr S; Plaza D; Ahmadian MR; Cavé H; Tartaglia M; Zenker M
Eur J Hum Genet; 2017 Jun; 25(7):823-831. PubMed ID: 28594414
[TBL] [Abstract][Full Text] [Related]
22. Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway: genotype-phenotype relationships and overlap with Costello syndrome.
Nava C; Hanna N; Michot C; Pereira S; Pouvreau N; Niihori T; Aoki Y; Matsubara Y; Arveiler B; Lacombe D; Pasmant E; Parfait B; Baumann C; Héron D; Sigaudy S; Toutain A; Rio M; Goldenberg A; Leheup B; Verloes A; Cavé H
J Med Genet; 2007 Dec; 44(12):763-71. PubMed ID: 17704260
[TBL] [Abstract][Full Text] [Related]
23. Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation.
Araki T; Mohi MG; Ismat FA; Bronson RT; Williams IR; Kutok JL; Yang W; Pao LI; Gilliland DG; Epstein JA; Neel BG
Nat Med; 2004 Aug; 10(8):849-57. PubMed ID: 15273746
[TBL] [Abstract][Full Text] [Related]
24. Mutation in NRAS in familial Noonan syndrome--case report and review of the literature.
Ekvall S; Wilbe M; Dahlgren J; Legius E; van Haeringen A; Westphal O; Annerén G; Bondeson ML
BMC Med Genet; 2015 Oct; 16():95. PubMed ID: 26467218
[TBL] [Abstract][Full Text] [Related]
25. A novel rasopathy caused by recurrent de novo missense mutations in PPP1CB closely resembles Noonan syndrome with loose anagen hair.
Gripp KW; Aldinger KA; Bennett JT; Baker L; Tusi J; Powell-Hamilton N; Stabley D; Sol-Church K; Timms AE; Dobyns WB
Am J Med Genet A; 2016 Sep; 170(9):2237-47. PubMed ID: 27264673
[TBL] [Abstract][Full Text] [Related]
26. Clinical and molecular characterization of children with Noonan syndrome and other RASopathies in Argentina.
Chinton J; Huckstadt V; Moresco A; Gravina LP; Obregon MG
Arch Argent Pediatr; 2019 Oct; 117(5):330-337. PubMed ID: 31560489
[TBL] [Abstract][Full Text] [Related]
27. Mutation Spectrum and Phenotypic Features in Noonan Syndrome with PTPN11 Mutations: Definition of Two Novel Mutations.
Atik T; Aykut A; Hazan F; Onay H; Goksen D; Darcan S; Tukun A; Ozkinay F
Indian J Pediatr; 2016 Jun; 83(6):517-21. PubMed ID: 26817465
[TBL] [Abstract][Full Text] [Related]
28. Providing more evidence on LZTR1 variants in Noonan syndrome patients.
Chinton J; Huckstadt V; Mucciolo M; Lepri F; Novelli A; Gravina LP; Obregon MG
Am J Med Genet A; 2020 Feb; 182(2):409-414. PubMed ID: 31825158
[TBL] [Abstract][Full Text] [Related]
29. Cardiovascular disease in Noonan syndrome.
Pierpont ME; Digilio MC
Curr Opin Pediatr; 2018 Oct; 30(5):601-608. PubMed ID: 30024444
[TBL] [Abstract][Full Text] [Related]
30. Craniosynostosis and Noonan syndrome with KRAS mutations: Expanding the phenotype with a case report and review of the literature.
Addissie YA; Kotecha U; Hart RA; Martinez AF; Kruszka P; Muenke M
Am J Med Genet A; 2015 Nov; 167A(11):2657-63. PubMed ID: 26249544
[TBL] [Abstract][Full Text] [Related]
31. Clinical analysis of Noonan syndrome caused by RRAS2 mutations and literature review.
Yu C; Lyn N; Li D; Mei S; Liu L; Shang Q
Eur J Med Genet; 2023 Jan; 66(1):104675. PubMed ID: 36460282
[TBL] [Abstract][Full Text] [Related]
32. [Arnold-Chiari malformation in Noonan syndrome and other syndromes of the RAS/MAPK pathway].
Ejarque I; Millán-Salvador JM; Oltra S; Pesudo-Martínez JV; Beneyto M; Pérez-Aytés A
Rev Neurol; 2015 May; 60(9):408-12. PubMed ID: 25912702
[TBL] [Abstract][Full Text] [Related]
33. Clinical and molecular characterization of 40 patients with Noonan syndrome.
Ferrero GB; Baldassarre G; Delmonaco AG; Biamino E; Banaudi E; Carta C; Rossi C; Silengo MC
Eur J Med Genet; 2008; 51(6):566-72. PubMed ID: 18678287
[TBL] [Abstract][Full Text] [Related]
34. Clinical report of a brain magnetic resonance imaging finding in Noonan syndrome.
D'Amico A; Cipullo MB; Falco M; Ugga L; Melis D
Childs Nerv Syst; 2021 Dec; 37(12):3963-3966. PubMed ID: 33811550
[TBL] [Abstract][Full Text] [Related]
35. [Noonan syndrome: genetic and clinical update and treatment options].
Carcavilla A; Suárez-Ortega L; Rodríguez Sánchez A; Gonzalez-Casado I; Ramón-Krauel M; Labarta JI; Quinteiro Gonzalez S; Riaño Galán I; Ezquieta Zubicaray B; López-Siguero JP
An Pediatr (Engl Ed); 2020 Jul; 93(1):61.e1-61.e14. PubMed ID: 32493603
[TBL] [Abstract][Full Text] [Related]
36. [Noonan syndrome: from phenotype to growth hormone therapy].
Malaquias AC; Ferreira LV; Souza SC; Arnhold IJ; Mendonça BB; Jorge AA
Arq Bras Endocrinol Metabol; 2008 Jul; 52(5):800-8. PubMed ID: 18797587
[TBL] [Abstract][Full Text] [Related]
37. [RAS/MAPK signal transduction pathway and its role in the pathogenesis of Noonan syndrome].
Gos M; Leszkiewicz M; Abramowicz A
Postepy Biochem; 2012; 58(3):255-64. PubMed ID: 23373411
[TBL] [Abstract][Full Text] [Related]
38. Variable phenotypic expression in a large Noonan syndrome family segregating a novel SOS1 mutation.
van Trier DC; Rinne T; Noordam K; Draaisma JM; van der Burgt I
Am J Med Genet A; 2017 Nov; 173(11):2968-2972. PubMed ID: 28884940
[TBL] [Abstract][Full Text] [Related]
39. Clinical Manifestations of Noonan Syndrome and Related Disorders.
Breilyn MS; Mehta L
Pediatr Endocrinol Rev; 2019 May; 16(Suppl 2):428-434. PubMed ID: 31115194
[TBL] [Abstract][Full Text] [Related]
40. Genetics and variation in phenotype in Noonan syndrome.
Jongmans M; Otten B; Noordam K; van der Burgt I
Horm Res; 2004; 62 Suppl 3():56-9. PubMed ID: 15539800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
